3-Bromopyridazine → 5-Methyl-2-(pyridazin-3-yl)benzoic acid

HRID 61126

Reaktionsgleichung

[CH3:1][C:2]1[CH:3]=[CH:4][C:5]([C:11]2[CH:16]=NC=C[N:12]=2)=[C:6]([CH:10]=1)[C:7]([OH:9])=[O:8].Br[C:18]1[N:19]=NC=C[CH:23]=1>>[CH3:1][C:2]1[CH:3]=[CH:4][C:5]([C:11]2[N:12]=[N:19][CH:18]=[CH:23][CH:16]=2)=[C:6]([CH:10]=1)[C:7]([OH:9])=[O:8]

Komponenten

Edukt 2

HCID 131266993-Bromopyridazine

HCID 811116085-Methyl-2-(2-pyrazinyl)benzoic acid

Produkt 1

HCID 1177277195-Methyl-2-(pyridazin-3-yl)benzoic acid

Versuchsvorschrift

The title compound was prepared following the same general protocol as described for 5-methyl-2-(pyrazin-2-yl)benzoic acid in Example A19, starting with 3-bromopyridazine. ESI-MS (m/z): 215 [M+1]+.

Quellen und Nachweise

ORD-Eintrag: ord-9ad7ab46b1ac411b812e5488e0181785
Quelldatensatz: uspto-grants-2016_09
DOI: 10.6084/m9.figshare.5104873.v1
Patentnummer: US09440982B2

Verknüpfte Notizen

Wird geladen…